Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: Involvement in osteoblastogenesis and osteoclastogenesis

Cell and Tissue Research

Volumn 357, Issue 1, 2014, Pages 245-252

  Yamaguchi, Masayoshi ^a   Zhu, Shijun ^a   Zhang, Shumin ^a   Wu, Daqing ^a   Moore, Terry M ^c   Snyder, James P ^b   Shoji, Mamoru ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anti cancer drug; Bone marrow; Bone metastasis; Breast cancer; Curcumin analogue UBS109; Osteoblastogenesis; Osteoclastogenesis

Indexed keywords

3,5 BIS(2 PYRIDINYLMETHYLIDENE) 1 METHYL 4 PIPERIDONE; CURCUMIN; LIPOPOLYSACCHARIDE; UBS 109; UNCLASSIFIED DRUG; PIPERIDONE DERIVATIVE; PYRIDINE DERIVATIVE; UBS109;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE CHARACTERISTICS AND FUNCTIONS; BONE MARROW CELL; BONE METASTASIS; BONE MINERALIZATION; BONE RADIOGRAPHY; BONE TISSUE; BREAST CANCER; CANCER CELL; CANCER MODEL; CELL STIMULATION; CELL STRAIN; CELL STRAIN MDA MB 231; CONTROLLED STUDY; DIAGNOSTIC IMAGING EQUIPMENT; DRUG EFFECT; EX VIVO STUDY; FEMALE; FEMUR; HINDLIMB; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOBLAST; OSTEOBLASTOGENESIS; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; TIBIA; TREATMENT DURATION; ANIMAL; BONE NEOPLASMS; BREAST NEOPLASMS; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; METASTASIS; OSTEOCLAST; PATHOLOGY; PREVENTION AND CONTROL; SECONDARY;

MUS; MUS MUSCULUS;

ANIMALS; BONE NEOPLASMS; BONE RESORPTION; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASM METASTASIS; OSTEOBLASTS; OSTEOCLASTS; PIPERIDONES; PYRIDINES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904720596     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-014-1846-4     Document Type: Article

References (27)

1. Akhtari M, Mansuri J, Newman KA, Guise TM, Seth P (2008) Biology of brest cancer bone metastasis. Cancer Biol Ther 7:3-9
2. Boyce BF, Yoneda T, Guise TA (1999) Factors regulating the growth of metastasis cancer in bone. Endocr Relat Cancer 6:333-347 (Pubitemid 29459783)
3. Burstone MS (1958) Histochemical demonstration of acid phosphatase with napthol AS-phosphate. J Natl Cancer Inst 21:523-539
4. Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R, Guan K, Krebsbach PH, Wang CY (2009) Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 15:682-689
5. Chen Y-C, Sosnoski DM, Mastro AM (2010) Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res 12:215
6. Chen G, Deng C, Li YP (2012) TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8:272-288
7. Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165-176
8. Eliseev RA, Schwarz EM, Zuscik MJ, O'Keefe RJ, Drissi H, Rosier RN (2006) Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB. Exp Cell Res 312:40-50 (Pubitemid 41668590)
9. Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, Enwert R, Branstetter D, Dougall WC (2010) RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 468:103-107
10. Guo R, Yamashita M, Zhang Q, Zhou Q, Chen D, Reynolds DG, Awad HA, Yanoso L, Zhao L, Schwarz EM, Zhang YE, Boyce BF, Xing L (2008) Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J Biol Chem 283:23084-23092
11. Hiraga T, Williams PJ, Mundy GR, Yoneda T (2001) The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res 61:4418-4424 (Pubitemid 32685769)
12. Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN (2007) Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation, through NF-kappaB. J Bone Miner Res 22:646-655 (Pubitemid 351339092)
13. Minkin C (1982) Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker osteoclast function. Calcif Tissue Int 34:285-290
14. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584-593
15. Nagaraju GP, Zhu S, Wen J, Farris AB, Adsay VN, Diaz R, Snyder JP, Shoji M, El-Rayes BF (2013) Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer. Cancer Lett 341:195-203
16. Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang C-Y (2007) NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 13:62-69 (Pubitemid 46067387)
17. Roodman CD (2004) Mechanism of bone metastasis. N Engl J Med 350:1655-1664
18. Seo SI, Gera L, Zhau HE, Qian WP, Iqbal S, Johnson NA, Zhang S, Zayzafoon M, Stewart J, Wang R, Chung LWK, Wu D (2008) BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis. Clin Cancer Res 14:6198-6206
19. Sun A, Lu YJ, Hu H, Shoji M, Liotta DC, Snyder JP (2009) Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism. Bioorg Med Chem Lett 19:6627-6631
20. Weilbaecher KN, Guise TA, McCauley LK (2011) Cancer to bone: a fatal attraction. Nat Rev Cancer 11:411-425
21. Wharton K, Derynck R (2009) TGF beta family signaling: novel insights in development and disease. Development 136:3691-3697
22. YamaguchiM, Uchiyama S (2005) Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures. J Cell Biochem 94:794-803 (Pubitemid 41420276)
23. Yamaguchi M, Moore TW, Sun A, Snyder JP, Shoji M (2012a) Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis through Smad activation and NF-κB Inhibition. Integr Biol (Camb) 4:905-913
24. Yamaguchi M, Weitzmann MN, Baile CA, Murata T (2012b) Exogenous regucalcin suppresses osteoblastogenesis and stimulates adipogenesis in mouse bone marrow culture. Integr Biol (Camb) 4:1215-1222
25. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brainseeking clone in vivo and in vitro. J BoneMiner Res 16:1486-1495 (Pubitemid 32675200)
26. Zaidi M, Blair HC, Moonga BS, Abe E, Huang CL-H (2003) Osteoclastogenesis, bone resorption, and osteoblast-based therapeutics. J Bone Miner Res 18:599-609 (Pubitemid 36899309)
27. Zhu S, Moore TW, Lin X, Morii N, Mancini A, Howard RB, Culver D, Arrendale RF, Reddy P, Evers TJ, Zhang H, Sica G, Chen ZG, Sun A, Fu H, Khuri FR, Shin DM, Snyder JP, Shoji M (2012) Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts. Integ Biol (Camb) 4:633-640